Abarelix en es it fr

Abarelix Brand names, Abarelix Analogs

Abarelix Brand Names Mixture

  • No information avaliable

Abarelix Chemical_Formula


Abarelix RX_link


Abarelix fda sheet

Abarelix msds (material safety sheet)

Abarelix Synthesis Reference

No information avaliable

Abarelix Molecular Weight


Abarelix Melting Point

No information avaliable

Abarelix H2O Solubility

No information avaliable

Abarelix State


Abarelix LogP

No information avaliable

Abarelix Dosage Forms

Suspension (IM Injection)

Abarelix Indication

For palliative treatment of advanced prostate cancer.

Abarelix Pharmacology

Used in the palliative treatment of advanced prostate cancer. Abarelix is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis.

Abarelix Absorption

Following IM administration of 100 mg, abarelix is absorbed slowly with a mean peak concentration of 43.4 ng/mL observed approximately 3 days after the injection.

Abarelix side effects and Toxicity

The maximum tolerated dose of abarelix has not been determined. The maximum dose used in clinical studies was 150 mg. There have been no reports of accidental overdose with abarelix.

Abarelix Patient Information

No information avaliable

Abarelix Organisms Affected

Humans and other mammals